Purpose:To assess the feasibility of magnetic resonance (MR) thermometry after thermoablative therapy and to quantitatively evaluate the ability of two sequence types to predict cell necrosis.
Methods:Twenty patients with hepatic tumors were treated by MR-guided radiofrequency ablation. For each 10 patients, postinterventionally performed gradient echo and segmented echo planar imaging sequences were used to calculate temperature maps based on the proton resonance frequency shift method. Contrast-enhanced images acquired 1 month after therapy were registered on the temperature maps and the necrotic, nonenhanced area was segmented and compared to the area with a displayed temperature above 60°C. Sensitivity and positive predictive value of the temperature map was calculated, using the follow-up imaging as the gold standard.
Results:Temperature mapping reached acceptable image quality in 45/47 cases. Sensitivity, ie, the rate of correctly detected coagulated tissue was 0.82 Ϯ 0.08 for the gradient echo imaging (GRE) sequence and 0.81 Ϯ 0.14 for the echo planar imaging (EPI) sequence. Positive predictive value, ie, the rate of voxel in the temperature map over 60°C that actually developed necrosis, was 0.90 Ϯ 0.07 for the GRE sequence and 0.84 Ϯ 0.11 for the EPI sequence.
Conclusion:Sequential MR temperature mapping allows for the prediction of the coagulation zone with an acceptable sensitivity and positive predictive value using EPI and GRE sequences. REAL-TIME TEMPERATURE MAPPING of magnetic resonance (MR)-guided minimally invasive radiofrequency (RF) ablation has been shown to be feasible both ex vivo (1) and in vivo (2-5), and has the potential of becoming the gold standard for therapy monitoring of thermoablative therapies. Different MR techniques have been proposed for temperature measurement (6 -10); the most frequently used is the proton resonance frequency shift (PRF) method (11-14), which is based on a temperature-dependent phase shift allowing for the measurement of temperature changes relative to a baseline image. With frequent repetitive measurements during thermoablative therapy, this approach allows a precise estimation of the lethal thermal dose (15) based on the Arrhenius model (16,17) and could be used to predict the size and position of the coagulation zone in animal studies (3,5). Furthermore, real-time temperature monitoring could allow for visualizing a vessel-related cooling effect and thus prevent a survival of cancer cells due to an undetected heat-sink effect.Due to technical and medical challenges linked to this approach, the majority of the literature up to now concerns preclinical questions. In case of RF ablation, the simultaneous use of an RF generator with frequencies between 300 and 500 kHz during imaging decreases image quality (6,18). To date, only noncommercial filters were used to overcome this problem (4,18) or generators with an adapted frequency were employed in animal studies (3,19). Therefore, we performed temperature measurement with a sequential approach: The sedated pat...